Impaired endothelium-derived hyperpolarizing factor-mediated relaxation in porcine pulmonary microarteries after cold storage with Euro-Collins and University of Wisconsin solutions

J Thorac Cardiovasc Surg. 2003 Jul;126(1):208-15. doi: 10.1016/s0022-5223(02)73615-5.

Abstract

Background: Endothelium plays an important role in mediating the function of transplanted organs. The widely used University of Wisconsin solution impairs the endothelium-derived hyperpolarizing factor-mediated relaxation in coronary arteries, but little is known about effects of lung preservation on endothelium-derived hyperpolarizing factor-mediated endothelial function. This study examined the effect of organ preservation solutions on the endothelium-derived hyperpolarizing factor-mediated relaxation in the pulmonary microarteries (diameter 200 to 450 microm).

Methods: Two segments (1 as control) from the same microartery were allocated in 2 chambers of a myograph. After incubation with hyperkalemia (potassium 115 mmol/L), University of Wisconsin, or Euro-Collins solution (at 4 degrees C for 4 hours), the endothelium-derived hyperpolarizing factor-mediated relaxation was induced by bradykinin (-10 to -6.5 log M, n = 8) or calcium ionophore (A(23187), -9 to -5.5 log M, n = 7) in U(46619) (-7.5 log M) precontracted rings in the presence of indomethacin (7 micromol/L), N(G)-nitro-L-arginine (300 micromol/L), and oxyhemoglobin (20 micromol/L).

Results: Exposure to hyperkalemia and storage with Euro-Collins or University of Wisconsin solution significantly decreased the relaxation to bradykinin (51.9 +/- 8.4% vs 60.3 +/- 6.1%, P =.02 or 49.3 +/- 7.3% vs 65.2 +/- 3.5%, P =.04) or A(23187) (12.5 +/- 0.02% vs 33.8 +/- 0.07%, P =.02 or 13.2 +/- 0.03% vs 31.0 +/- 0.05%, P =.03%).

Conclusions: Endothelium-derived hyperpolarizing factor plays an important role in porcine pulmonary microarteries, and the endothelium-derived hyperpolarizing factor-mediated relaxation is impaired when the lung is preserved with University of Wisconsin or Euro-Collins solution. This impairment may affect the lung function during the reperfusion period after lung transplantation.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid / pharmacology
  • Animals
  • Blood Pressure / drug effects
  • Blood Pressure / physiology
  • Bradykinin / pharmacology
  • Calcimycin / pharmacology
  • Cold Temperature*
  • Dose-Response Relationship, Drug
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / physiology
  • Hyperkalemia
  • Hypertonic Solutions / pharmacology*
  • Ionophores / pharmacology
  • Lung*
  • Models, Animal
  • Models, Cardiovascular
  • Muscle Contraction / drug effects
  • Muscle Contraction / physiology
  • Nitric Oxide / pharmacology*
  • Organ Preservation Solutions / pharmacology*
  • Pulmonary Artery / drug effects*
  • Pulmonary Artery / physiology*
  • Swine
  • Vasoconstrictor Agents / pharmacology
  • Vasodilation / drug effects*
  • Vasodilation / physiology*
  • Vasodilator Agents / pharmacology*

Substances

  • Euro-Collins' solution
  • Hypertonic Solutions
  • Ionophores
  • Organ Preservation Solutions
  • Vasoconstrictor Agents
  • Vasodilator Agents
  • Nitric Oxide
  • Calcimycin
  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
  • Bradykinin